🇺🇸 FDA
Patent

US 8900818

Recombinant antigen for diagnosis and prevention of murine typhus

granted A61KA61K39/0233A61P

Quick answer

US patent 8900818 (Recombinant antigen for diagnosis and prevention of murine typhus) held by United States of America as represented by the Secretary of the Air Force expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K39/0233, A61P, A61P31/04, A61P37/04